Keyword Search Subscribe to receive breaking news alerts about uniQure. Subscribe Year None20232022202120202019201820172016 Date Title Oct 02, 2023 uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 05, 2023 uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy Aug 01, 2023 uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress Jun 26, 2023 uniQure Announces Leadership Addition to Support Advancement of Clinical Programs Jun 21, 2023 uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease Jun 20, 2023 uniQure announces achievement of $100 million milestone related to hemophilia B gene therapy Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »